SEARCH

SEARCH BY CITATION

References

  • Akira, S., Takeda, K. & Kaisho, T. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2, 675680.
  • Bassi, E. J., de Almeida, D. C., Moraes-Vieira, P. M., Câmara, N. O. 2012. Exploring the role of soluble factors associated with immune regulatory properties of mesenchymal stem cells. Stem Cell Rev. 8, 329342.
  • Chang, Y. J., Shih, D. T., Tseng, C. P., Hsieh, T. B., Lee, D. C., Hwang, S. M. 2006. Disparate mesenchyme-lineage tendencies in mesenchymal stem cells from human bone marrow and umbilical cord blood. Stem Cells 24, 679685.
  • Hwa Cho, H., Bae, Y. C. & Jung, J. S. 2006. Role of toll-like receptors on human adipose-derived stromal cells. Stem Cells 24, 27442752.
  • Iwasaki, A. & Medzhitov, R. 2004. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5, 987995.
  • Liotta, F., Angeli, R., Cosmi, L., Filì, L., Manuelli, C., Frosali, F., Mazzinghi, B., Maggi, L., Pasini, A., Lisi, V., Santarlasci, V., Consoloni, L., Angelotti, M. L., Romagnani, P., Parronchi, P., Krampera, M., Maggi, E., Romagnani, S., Annunziato, F. 2008. Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and inhibit their T-cell modulatory activity by impairing Notch signaling. Stem Cells 26, 279289.
  • Lundberg, A. M., Drexler, S. K., Monaco, C., Williams, L. M., Sacre, S. M., Feldmann, M., Foxwell, B. M. 2007. Key differences in TLR3/poly I: C signaling and cytokine induction by human primary cells: a phenomenon absent from murine cell systems. Blood 110, 32453252.
  • Ma, J., Ge, J., Zhang, S., Sun, A., Shen, J., Chen, L., Wang, K., Zou, Y. 2005. Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction. Basic Res. Cardiol. 100, 217223.
  • Opitz, C. A., Litzenburger, U. M., Lutz, C., Lutz, T. V., Tritschler, I., Köppel, A., Tolosa, E., Hoberg, M., Anderl, J.Aicher, W. K., Weller, M., Wick, W., Platten, M. 2009. Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2, 3-dioxygenase-1 via interferon-beta and protein kinase R. Stem Cells 27, 909919.
  • Pasare, C. & Medzhitov, R. 2004. Toll-like receptors: linking innate and adaptive immunity. Microbes Infect. 6, 13821387.
  • Pevsner-Fischer, M., Morad, V., Cohen-Sfady, M., Rousso-Noori, L., Zanin-Zhorov, A., Cohen, S., Cohen, I. R., Zipori, D. 2007. Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 109, 14221432.
  • Ringe, J., Strassburg, S., Neumann, K., Endres, M., Notter, M., Burmester, G.R., Kaps, C., Sittinger, M. 2007. Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2. J. Cell. Biochem. 101, 135146.
  • Romieu-Mourez, R., François, M., Boivin, M. N., Bouchentouf, M., Spaner, D. E., Galipeau, J. 2009. Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype. J. Immunol. 182, 79637973.
  • Shi, Y., Hu, G., Su, J., Li, W., Chen, Q., Shou, P., Xu, C., Chen, X., Huang, Y., Zhu, Z., Huang, X., Han, X., Xie, N., Ren, G. 2010. Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Cell Res. 20, 510518.
  • Si, Y. L., Zhao, Y. L., Hao, H. J., Fu, X. B., Han, W. D. 2011. MSCs: biological characteristics, clinical applications and their outstanding concerns. Ageing Res. Rev. 10, 93103.
  • Sordi, V., Malosio, M. L., Marchesi, F., Mercalli, A., Melzi, R., Giordano, T., Belmonte, N., Ferrari, G., Leone, B. E., Bertuzzi, F., Zerbini, G., Allavena, P., Bonifacio, E., Piemonti, L. 2005. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 106, 419427.
  • Sun, Y., Chen, L., Hou, X. G., Hou, W. K., Dong, J. J., Sun, L., Tang, K. X., Wang, B., Song, J., Li, H., Wang, K. X. 2007. Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro. Chin. Med. J. 120, 771776.
  • Tomchuck, S. L., Zwezdaryk, K. J., Coffelt, S. B., Waterman, R. S., Danka, E. S., Scandurro, A. B. 2008. Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses. Stem Cells 26, 99107.
  • Tse, W. T., Pendleton, J. D., Beyer, W. M., Egalka, M. C., Guinan, E. C. 2003. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75, 389397.
  • Waterman, R. S., Tomchuck, S. L., Henkle, S. L., Betancourt, A. M. 2010. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype. PLoS One 5, e10088.
  • Wehling, N., Palmer, G. D., Pilapil, C., Liu, F., Wells, J. W., Müller, P. E., Evans, C. H., Porter, R. M. 2009. Interleukin-1beta and tumor necrosis factor alpha inhibit chondrogenesis by human mesenchymal stem cells through NF-kappaB-dependent pathways. Arthritis Rheum. 60, 801812.
  • Xu, S., Evans, H., Buckle, C., De. Veirman, K., Hu, J., Xu, D., Menu, E., De. Becker, A., Vande Broek, I., Leleu, X., Camp, B. V., Croucher, P., Vanderkerken, K., Van Riet, I. 2012. Impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients is associated with a blockade in the deactivation of the Notch signaling pathway. Leukemia 26, 25462549.
  • Yamaguchi, M. & Weitzmann, M. N. 2012. The intact strontium ranelate complex stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-κB activation. Mol. Cell. Biochem. 359, 399407.
  • Yarmo, M. N., Gagnon, A. & Sorisky, A. 2010. The anti-adipogenic effect of macrophage-conditioned medium requires the IKKβ/NF-κB pathway. Horm. Metab. Res. 42, 831836.
  • Zhao, R. C., Liao, L. & Han, Q. 2004. Mechanisms of and perspectives on the mesenchymal stem cell in immunotherapy. J. Lab. Clin. Med. 143, 284291.
  • Zhao, Z. G., Xu, W., Sun, L., You, Y., Li, F., Li, Q. B., Zou, P. 2012. Immunomodulatory function of regulatory dendritic cells induced by mesenchymal stem cells. Immunol. Invest. 41, 183198.
  • Zhukareva, V., Obrocka, M., Houle, J. D., Fischer, I., Neuhuber, B. 2010. Secretion profile of human bone marrow stromal cells: donor variability and response to inflammatory stimuli. Cytokine 50, 317321.